- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x CMO: CARBON MONOXIDE(Non-functional Binders)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.2: 19 residues within 4Å:- Chain A: Y.43, F.44, H.46, F.47, H.59, K.62, A.66, L.67, L.84, L.87, H.88, L.92, V.94, N.98, F.99, L.102, S.134, L.137
- Ligands: CMO.1
18 PLIP interactions:18 interactions with chain A,- Hydrophobic interactions: A:Y.43, A:Y.43, A:F.44, A:F.44, A:F.47, A:A.66, A:L.67, A:L.84, A:L.92, A:V.94, A:F.99, A:F.99, A:F.99, A:L.137
- Salt bridges: A:H.46, A:H.59, A:K.62
- Metal complexes: A:H.88
HEM.5: 18 residues within 4Å:- Chain B: T.39, F.42, F.43, H.64, K.67, V.68, A.71, F.72, L.89, L.92, H.93, L.97, V.99, N.103, F.104, L.107, L.142
- Ligands: CMO.4
18 PLIP interactions:18 interactions with chain B,- Hydrophobic interactions: B:T.39, B:F.42, B:F.42, B:F.43, B:F.43, B:V.68, B:A.71, B:F.72, B:L.89, B:L.97, B:V.99, B:N.103, B:F.104, B:L.142
- Water bridges: B:H.64, B:K.67
- Salt bridges: B:K.67
- Metal complexes: B:H.93
HEM.7: 19 residues within 4Å:- Chain C: M.33, Y.43, F.44, F.47, H.59, K.62, V.63, A.66, L.67, L.84, L.87, H.88, L.92, V.94, N.98, F.99, L.102, L.137
- Ligands: CMO.6
20 PLIP interactions:20 interactions with chain C,- Hydrophobic interactions: C:Y.43, C:Y.43, C:F.44, C:F.44, C:F.47, C:V.63, C:A.66, C:L.67, C:L.84, C:L.92, C:V.94, C:N.98, C:F.99, C:F.99, C:L.102, C:L.102, C:L.137
- Water bridges: C:Y.43
- Salt bridges: C:K.62
- Metal complexes: C:H.88
HEM.10: 18 residues within 4Å:- Chain D: T.39, F.42, F.43, F.46, H.64, K.67, A.71, F.72, L.89, L.92, H.93, L.97, V.99, N.103, F.104, L.107, L.142
- Ligands: CMO.9
19 PLIP interactions:19 interactions with chain D,- Hydrophobic interactions: D:T.39, D:F.42, D:F.42, D:F.43, D:F.43, D:A.71, D:L.89, D:L.92, D:L.97, D:V.99, D:V.99, D:N.103, D:F.104, D:L.107, D:L.142
- Water bridges: D:H.64, D:K.67
- Salt bridges: D:H.64
- Metal complexes: D:H.93
- 2 x VZN: {6-[(3-hydroxy-2-methylphenoxy)methyl]pyridin-2-yl}methyl nitrate(Covalent)
VZN.3: 14 residues within 4Å:- Chain A: V.2, V.74, D.75, D.76, M.77, P.78, K.128, A.131, S.132, T.135
- Chain C: V.2, T.135, S.139
- Ligands: VZN.8
8 PLIP interactions:4 interactions with chain A, 4 interactions with chain C- Hydrophobic interactions: A:V.2, A:P.78, C:V.2, C:T.135, C:T.135
- Hydrogen bonds: A:V.2, C:S.139
- Water bridges: A:K.8
VZN.8: 14 residues within 4Å:- Chain A: V.2, T.135, S.139
- Chain C: V.2, V.74, D.75, D.76, M.77, P.78, K.128, A.131, S.132, T.135
- Ligands: VZN.3
8 PLIP interactions:3 interactions with chain A, 5 interactions with chain C- Hydrophobic interactions: A:V.2, A:T.135, C:V.2, C:P.78
- Hydrogen bonds: A:S.139, C:V.2, C:V.2, C:M.77
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, B. et al., Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease. Molecules (2022)
- Release Date
- 2022-11-16
- Peptides
- Hemoglobin subunit alpha: AC
Hemoglobin subunit beta: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 4 x CMO: CARBON MONOXIDE(Non-functional Binders)
- 4 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x VZN: {6-[(3-hydroxy-2-methylphenoxy)methyl]pyridin-2-yl}methyl nitrate(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Huang, B. et al., Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease. Molecules (2022)
- Release Date
- 2022-11-16
- Peptides
- Hemoglobin subunit alpha: AC
Hemoglobin subunit beta: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D